aflibercept vs brinzolamide
Side-by-side comparison of aflibercept and brinzolamide Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Eylea
Azopt
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Azopt eye drops contain brinzolamide, which lowers pressure in the eye. It is used to treat glaucoma and ocular hypertension.
AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
Azopt is used to treat high pressure inside the eye. This high pressure can be caused by ocular hypertension or open-angle glaucoma. By lowering the pressure, Azopt helps to prevent damage to the optic nerve and vision loss.
AHZANTIVE is a VEGF inhibitor. VEGF is a protein that promotes the growth of new blood vessels. By blocking VEGF, AHZANTIVE helps to reduce the growth of abnormal blood vessels in the eye and decrease leakage.
Azopt contains brinzolamide, which is a carbonic anhydrase inhibitor. It works by decreasing the production of fluid in the eye. This helps to lower the pressure inside the eye.
- • Bleeding in the eye
- • Eye pain
- • Clouding of the lens of the eye (cataract)
- • Separation of the vitreous gel from the retina
- • Spots in your vision
- • Blurred vision
- • Bitter, sour, or unusual taste
- Death 7,853
- Trouble seeing 2,013
- Using the medicine for something it's not approved for 1,509
- Loss of sight 1,459
- Eye infection 1,372
- The medicine did not work 1,429
- Difficulty breathing 564
- The drug is not working 499
- Feeling lightheaded or unsteady 479
- Pain in the eye 468
Injections with AHZANTIVE may cause serious eye infections (endophthalmitis), separation of the retina (retinal detachment), and inflammation of blood vessels in the retina. Tell your doctor right away if you have any signs of these problems. AHZANTIVE may also increase the risk of blood clots that can cause stroke or heart attack.
Azopt is a sulfonamide drug, and serious reactions can occur, though rarely. If you have signs of a serious reaction or hypersensitivity, stop using Azopt right away. If you have a low number of cells in the cornea, use Azopt with caution, as corneal edema may occur. Azopt is not recommended if you have severe kidney problems.
It is not known if AHZANTIVE can harm an unborn baby. AHZANTIVE should be used during pregnancy only if the benefit justifies the risk. It is also not known if AHZANTIVE passes into breast milk.
It is not known if Azopt can harm an unborn baby. Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Also Compare — Nearby Drugs
Compare aflibercept with
Compare brinzolamide with
How to Read This aflibercept vs brinzolamide Comparison
aflibercept is classified in the Anti-VEGF (Ophthalmic Injection) drug class, while brinzolamide sits within the Carbonic Anhydrase Inhibitor (Ophthalmic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aflibercept has 14,206 submissions while brinzolamide has 3,439. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aflibercept and brinzolamide — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.